Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance

Published:2021-02 Issue: Volume:330 Page:920-932
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kim Jinseong,Shim Man Kyu,Yang Suah,Moon Yujeong,Song Sukyung,Choi Jiwoong,Kim Jeongrae,Kim Kwangmeyung

Funder

Korea University

Korea Institute of Science and Technology

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference31 articles.

1. Treatment options for advanced endometrial carcinoma;Dizon;Gynecol. Oncol.,2010

2. Nanotechnology applied to overcome tumor drug resistance;Gao;J. Control. Release,2012

3. Drug resistance in cancer: an overview;Housman;Cancers (Basel),2014

4. Multicenter phase II trial of Temozolomide in mycosis Fungoides/Sézary syndrome: correlation with O6-Methylguanine-DNA methyltransferase and mismatch repair proteins;Querfeld;Clin. Cancer Res.,2011

5. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in 2,3-Dimethylmaleic Anhydride (DMMA)-Modified Nanocarriers in Drug Delivery Systems;Pharmaceutics;2024-06-14

2. Two‐pronged reversal of chemotherapy resistance by gold nanorods induced mild photothermal effect;Bioengineering & Translational Medicine;2024-04-18

3. Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy;Biomolecules & Therapeutics;2024-04-09

4. Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors;Expert Opinion on Drug Delivery;2024-04-02

5. Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance;International Journal of Pharmaceutics;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3